Symmetry Partners, LLC Abb Vie Inc. Transaction History

Symmetry Partners, LLC

$422 Million
Q3 2024

A detailed history of Symmetry Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Symmetry Partners, LLC holds 1,307 shares of ABBV stock, worth $230,293. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,307

Previous 14,514 90.99%

Holding current value

$230,293

Previous $2.49 Million 89.63%

% of portfolio

0.06%

Previous 0.13%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$163.84 - $199.33 $2.16 Million - $2.63 Million	-13,207 Reduced 90.99%	1,307 $258,000
Q2 2024 Jul 11, 2024	SELL	$154.79 - $180.76 $323,975 - $378,330	-2,093 Reduced 12.6%	14,514 $2.49 Million
Q1 2024 Apr 02, 2024	SELL	$159.82 - $182.1 $172,765 - $196,850	-1,081 Reduced 6.11%	16,607 $3.02 Million
Q4 2023 Jan 02, 2024	SELL	$137.6 - $154.97 $33,436 - $37,657	-243 Reduced 1.36%	17,688 $2.74 Million
Q3 2023 Oct 10, 2023	SELL	$133.59 - $154.65 $689,858 - $798,612	-5,164 Reduced 22.36%	17,931 $2.67 Million
Q2 2023 Jul 05, 2023	SELL	$132.51 - $164.9 $1.92 Million - $2.39 Million	-14,508 Reduced 38.58%	23,095 $3.11 Million
Q1 2023 Apr 03, 2023	BUY	$144.61 - $166.54 $80,547 - $92,762	557 Added 1.5%	37,603 $5.99 Million
Q4 2022 Jan 06, 2023	SELL	$138.31 - $165.87 $397,226 - $476,378	-2,872 Reduced 7.19%	37,046 $5.99 Million
Q3 2022 Oct 03, 2022	BUY	$134.21 - $153.93 $1.47 Million - $1.68 Million	10,920 Added 37.66%	39,918 $5.36 Million
Q2 2022 Jul 11, 2022	SELL	$137.62 - $174.96 $858,335 - $1.09 Million	-6,237 Reduced 17.7%	28,998 $4.44 Million
Q1 2022 Apr 04, 2022	BUY	$131.98 - $163.75 $810,621 - $1.01 Million	6,142 Added 21.11%	35,235 $5.71 Million
Q4 2021 Jan 11, 2022	BUY	$107.43 - $135.93 $68,218 - $86,315	635 Added 2.23%	29,093 $3.94 Million
Q3 2021 Oct 18, 2021	SELL	$106.4 - $120.78 $85,120 - $96,624	-800 Reduced 2.73%	28,458 $3.12 Million
Q2 2021 Jul 07, 2021	SELL	$105.21 - $117.21 $991,288 - $1.1 Million	-9,422 Reduced 24.36%	29,258 $3.3 Million
Q1 2021 May 03, 2021	BUY	$102.3 - $112.62 $25,984 - $28,605	254 Added 0.66%	38,680 $4.19 Million
Q4 2020 Feb 18, 2021	SELL	$80.49 - $108.67 $365,988 - $494,122	-4,547 Reduced 10.58%	38,426 $4.12 Million
Q3 2020 Nov 03, 2020	BUY	$85.91 - $100.83 $2.01 Million - $2.35 Million	23,346 Added 118.95%	42,973 $3.76 Million
Q2 2020 Jul 20, 2020	BUY	$73.37 - $98.18 $1.16 Million - $1.55 Million	15,775 Added 409.53%	19,627 $1.93 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $248,454 - $376,687	3,852 New	3,852 $293,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $312B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Symmetry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Symmetry Partners, LLC with notifications on news.

Account

Symmetry Partners, LLC Abb Vie Inc. Transaction History